PROCEPT BioRobotics (PRCT)
(Delayed Data from NSDQ)
$67.29 USD
+1.74 (2.65%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $67.25 -0.04 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for PROCEPT BioRobotics Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -105.90 | -87.15 | -59.85 | -53.02 | NA |
Depreciation/Amortization & Depletion | 3.81 | 2.84 | 3.32 | 2.86 | NA |
Net Change from Assets/Liabilities | -26.16 | -11.49 | -4.71 | -0.48 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 20.25 | 15.42 | 3.90 | 2.30 | NA |
Net Cash From Operating Activities | -108.00 | -80.38 | -57.33 | -48.34 | NA |
Property & Equipment | -25.21 | -2.65 | -0.59 | -0.23 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -25.21 | -2.65 | -0.59 | -0.23 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 167.80 | 6.42 | 262.12 | 82.09 | NA |
Issuance (Repayment) of Debt | 0.00 | 1.20 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 24.69 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | -4.00 | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | 167.80 | 3.61 | 262.12 | 106.77 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 34.59 | -79.42 | 204.19 | 58.20 | NA |
Cash at Beginning of Period | 225.67 | 305.10 | 100.91 | 42.71 | NA |
Cash at End of Period | 260.26 | 225.67 | 305.10 | 100.91 | NA |
Diluted Net EPS | -2.24 | -1.96 | -3.63 | NA | NA |
Fiscal Year End for PROCEPT BioRobotics Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -25.96 | -105.90 | -78.39 | -53.77 | -28.48 |
Depreciation/Amortization & Depletion | 1.18 | 3.81 | 2.49 | 1.44 | 0.79 |
Net Change from Assets/Liabilities | -13.70 | -26.16 | -22.66 | -21.54 | -12.71 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.19 | 20.25 | 15.35 | 9.61 | 4.47 |
Net Cash From Operating Activities | -32.29 | -108.00 | -83.21 | -64.27 | -35.93 |
Property & Equipment | -1.95 | -25.21 | -16.49 | -10.71 | -5.34 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -1.95 | -25.21 | -16.49 | -10.71 | -5.34 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.59 | 167.80 | 164.93 | 2.81 | 0.38 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 2.59 | 167.80 | 164.93 | 2.81 | 0.38 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -31.65 | 34.59 | 65.23 | -72.17 | -40.89 |
Cash at Beginning of Period | 260.26 | 225.67 | 225.67 | 225.67 | 225.67 |
Cash at End of Period | 228.61 | 260.26 | 290.90 | 153.51 | 184.79 |
Diluted Net EPS | -0.51 | -0.54 | -0.51 | -0.56 | -0.63 |